DK0644763T3 - Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triacin-isethionat til behandlingen og forebyggelsen af afhængighed, tolerance og sensitivering af medikamenter - Google Patents

Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triacin-isethionat til behandlingen og forebyggelsen af afhængighed, tolerance og sensitivering af medikamenter

Info

Publication number
DK0644763T3
DK0644763T3 DK93913346.8T DK93913346T DK0644763T3 DK 0644763 T3 DK0644763 T3 DK 0644763T3 DK 93913346 T DK93913346 T DK 93913346T DK 0644763 T3 DK0644763 T3 DK 0644763T3
Authority
DK
Denmark
Prior art keywords
tolerance
dichlorophenyl
diamino
pct
triacin
Prior art date
Application number
DK93913346.8T
Other languages
English (en)
Inventor
Meire Nakamura-Craig
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929212495A external-priority patent/GB9212495D0/en
Priority claimed from GB939308654A external-priority patent/GB9308654D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0644763T3 publication Critical patent/DK0644763T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK93913346.8T 1992-06-12 1993-06-11 Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triacin-isethionat til behandlingen og forebyggelsen af afhængighed, tolerance og sensitivering af medikamenter DK0644763T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929212495A GB9212495D0 (da) 1992-06-12 1992-06-12
GB939308654A GB9308654D0 (en) 1993-04-27 1993-04-27 Therapeutic triazine compounds and use

Publications (1)

Publication Number Publication Date
DK0644763T3 true DK0644763T3 (da) 1997-07-28

Family

ID=26301060

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93913346.8T DK0644763T3 (da) 1992-06-12 1993-06-11 Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triacin-isethionat til behandlingen og forebyggelsen af afhængighed, tolerance og sensitivering af medikamenter

Country Status (23)

Country Link
US (1) US5801171A (da)
EP (1) EP0644763B1 (da)
JP (1) JP3439211B2 (da)
KR (1) KR100268823B1 (da)
AT (1) ATE147980T1 (da)
AU (1) AU688729B2 (da)
CA (1) CA2137782A1 (da)
CZ (1) CZ284061B6 (da)
DE (1) DE69307705T2 (da)
DK (1) DK0644763T3 (da)
ES (1) ES2097516T3 (da)
GB (1) GB2282326A (da)
GR (1) GR3022671T3 (da)
HR (1) HRP930964B1 (da)
IL (1) IL105986A (da)
MY (1) MY109330A (da)
NO (1) NO306451B1 (da)
NZ (1) NZ253260A (da)
SI (1) SI9300318A (da)
SK (1) SK279730B6 (da)
TW (1) TW284689B (da)
WO (1) WO1993025207A1 (da)
YU (1) YU48573B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU182086B (en) * 1979-06-01 1983-12-28 Wellcome Found Process for preparing new 1,2,4-triazine derivatives
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
YU41093A (sh) 1996-10-09
HRP930964B1 (en) 2000-06-30
SI9300318A (en) 1994-03-31
KR950701814A (ko) 1995-05-17
JPH07507790A (ja) 1995-08-31
WO1993025207A1 (en) 1993-12-23
SK279730B6 (sk) 1999-02-11
DE69307705D1 (de) 1997-03-06
CA2137782A1 (en) 1993-12-23
CZ284061B6 (cs) 1998-08-12
GB9423697D0 (en) 1995-01-11
JP3439211B2 (ja) 2003-08-25
NO306451B1 (no) 1999-11-08
CZ312894A3 (en) 1995-07-12
MY109330A (en) 1997-01-31
KR100268823B1 (ko) 2000-12-01
NO944790L (no) 1994-12-09
NO944790D0 (no) 1994-12-09
US5801171A (en) 1998-09-01
DE69307705T2 (de) 1997-05-22
ES2097516T3 (es) 1997-04-01
EP0644763B1 (en) 1997-01-22
SK153494A3 (en) 1996-01-10
TW284689B (da) 1996-09-01
IL105986A0 (en) 1993-10-20
YU48573B (sh) 1998-12-23
AU688729B2 (en) 1998-03-19
NZ253260A (en) 1997-05-26
AU4345293A (en) 1994-01-04
EP0644763A1 (en) 1995-03-29
HRP930964A2 (en) 1996-02-29
GB2282326A (en) 1995-04-05
ATE147980T1 (de) 1997-02-15
GR3022671T3 (en) 1997-05-31
IL105986A (en) 1998-12-06

Similar Documents

Publication Publication Date Title
NO985494D0 (no) Pyrazoler og pyrazolopyrimidiner med CRF antagonist aktivitet
SE8802570D0 (sv) New use of 5ht-3 antagonists
IL130659A0 (en) Phthalazinone compounds medicaments containing them and the use thereof
CO4440627A1 (es) Antagonistas de factor de liberacion de corticotropina
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
ES2185660T3 (es) Nuevo uso de dexmedetomidina.
BR9306361A (pt) Agentes para o tratamento de desordens resultantes do abuso de substâncias
DK0644763T3 (da) Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triacin-isethionat til behandlingen og forebyggelsen af afhængighed, tolerance og sensitivering af medikamenter
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
DK0626851T3 (da) Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triazin til fremstilling af et lægemiddel til behandling af visse typer af smerte og af ødem
PT1140080E (pt) Utilizacao de riluzole no tratamento de traumatismos acusticos
NZ332484A (en) use of pyridyl and pyrimidyl substituted piperazine derivatives for treating substance abuse disorders
DK0862462T3 (da) Kombination af en beta-receptorblokker og et opioid